Hepatitis c virus genotyping: Clinical implications and methods

Molecular Diagnosis

Volumn 6, Issue 4, 2001, Pages 265-277

  Nolte, Frederick S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genotyping; Hepatitis C virus; Nucleic acid sequencing

Indexed keywords

ALPHA INTERFERON; DNA FRAGMENT; HETERODUPLEX;

5' UNTRANSLATED REGION; DISEASE COURSE; GENOME; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; LIVER FAILURE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PATHOGENESIS; PHYLOGENY; REVIEW; VIRUS GENE;

EID: 0035678574     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.1054/modi.2001.29157     Document Type: Article

References (110)

1. Discovery of non-A, non-B hepatitis and identification of its etiology
2. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
3. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
4. Genetic heterogeneity of hepatitis C virus: Quasispecies and genotypes
5. Methods for determining the hepatitis C virus genotype
6. Clinical significance of hepatitis C virus genotypes
7. The molecular virology of hepatitis C
8. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
9. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: Comparative study of four distinct genotypes
10. At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide
11. Sequence analysis of the core gene of 14 hepatitis C virus genotypes
12. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region
13. Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups
14. Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11 a) genetic groups
15. Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes
16. Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: Comparison with classifications based upon sequence similarity
17. Hepatitis C virus genotypes: An investigation of type-specific differences in geographic origin and disease
18. Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaborative survey
19. Hepatitis C virus genotypes and hepatitis G virus in hemodialysis patients from Syria: Identification of two novel hepatitis C virus subtypes
20. The complete coding sequence of hepatitis C virus genotype 5a, the predominant genotype in South Africa
21. At least five related, but distinct, hepatitis C viral genotypes exist
22. Review: Molecular epidemiology of hepatitis C virus
23. Natural history of hepatitis C
24. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study
25. Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma
26. Hepatitis C virus type 1b (II) infection in France and Italy
27. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease
28. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities
29. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A case-control study
30. Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype lb
31. Hepatitis C virus genotypes in the United States: Epidemiology, pathogenicity and response to interferon therapy
32. Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation
33. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation
34. A longitudinal analysis of hepatitis C virus replication following liver transplantation
35. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis
36. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States
37. Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: Relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma
38. Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis
39. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups
40. Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients
41. Hepatitis C virus genotypes are not responsible for development of serious liver disease
42. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies
43. Degree of diversity of hepatitis C virus quasispecies and progression of liver disease
44. Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients
45. Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation
46. Hepatitis C virus genetic variability: Clinical implications
47. The changing relative prevalence of hepatitis C virus genotypes: Evidence in hemodialyzed patients and kidney recipients
48. Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak
49. Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin
50. Patient-to-patient transmission of hepatitis C virus during colonoscopy
51. Erroneous HCV genotype assignment by a hybridization typing assay in a case of posttransfusion HCV infection
52. A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants
53. Mother-to-child transmission of a hepatitis C virus variant with an insertional mutation in its hypervariable region
54. Molecular analysis of intraspousal transmission of hepatitis C virus
55. Acute hepatitis C infection after sexual exposure
56. Genotype-dependent serologic reactivities in patients infected with hepatitis C virus in the United States
57. Detection of three types of hepatitis C virus in blood donors: Investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities
58. Serological reactivity and viral genotypes in hepatitis C virus infection
59. Sequence analysis of the 5′ noncoding region of hepatitis C virus
60. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1,2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche monitor assay, and an in-house limiting dilution method
61. Implications of variations of "conserved" regions of hepatitis C virus genome
62. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology
63. Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: Calibration to international units, enhanced genotype reactivity, and performance characteristics
64. Albrecht J for the ALGOVIRC Project Group J Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C
65. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection
66. Number and position of mutations in the interferon (IFN) sensitivity-determining region of the gene for nonstructural protein 5A correlate with IFN efficacy in hepatitis C virus 1b infection
67. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity
68. Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b
69. Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type lb undergoing combination therapy
70. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa
71. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation
72. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein
73. Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3a and correlation with treatment response
74. Differential sensitivity of hepatitis C virus quasispecies to interferon-alpha therapy
75. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): Influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C
76. The degree of variability in the amino terminal region of the E2/NSI protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients
77. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients
78. Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C
79. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: Correlation with response to interferon therapy
80. Quasispecies nature of hepatitis C virus and response to alpha interferon: Significance as a predictor of direct response to interferon
81. Variation of the hepatitis C virus 5′non-coding region: Implications for secondary structure, virus detection and typing
82. How Escherichia coli can bias the results of molecular cloning: Preferential selection of defective genomes of hepatitis C virus during the cloning procedure
83. Virus 'quasispecies': Making a mountain out of a molehill?
84. Genotyping of hepatitis C virus isolates using CLIP sequencing
85. Hepatitis C virus genotyping based on 5' noncoding sequency analysis (Trugene)
86. Evaluation of a new hepatitis C virus sequencing assay as a routine method for genotyping
87. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
88. Second-generation line probe assay for hepatitis C virus genotyping
89. Subtyping of hepatitis C virus isolates by a line probe assay using hybridization
90. Evaluation of a reverse hybridization assay for genotyping of hepatitis C virus
91. Typing of hepatitis C virus isolates by DNA enzyme immunoassay
92. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources
93. Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients
94. Rapid genotyping of hepatitis C virus RNA-isolates obtained from patients residing in western Europe
95. Genotyping of hepatitis C virus isolates by a modified polymerase chain reaction assay using type specific primers: Epidemiological applications
96. Comparative analysis of two assays for genotyping hepatitis C virus based on genotype-specific primers or probes
97. Genotypic subtyping of hepatitis C virus
98. New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a
99. A second-generation method of genotyping hepatitis C virus by the polymerase chain reaction with sense and antisense primers deduced from the core gene
100. Primer specific and mispair extension analysis (PSMEA) as a simple approach to fast genotyping
101. Comparison and application of a novel genotyping method, semiautomated primer-specific and mispair extension analysis, and four other genotyping assays for detection of hepatitis C virus mixed-genotype infections
102. Nested restriction site-specific PCR to detect and type hepatitis C virus (HCV): A rapid method to distinguish HCV subtype 1b from other genotypes
103. Typing of hepatitis C virus genomes by restriction fragment length polymorphism
104. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region
105. Determination of hepatitis C virus genotypes in the United States by cleavase fragment length polymorphism analysis
106. Algorithmic approach to high-throughput molecular screening for alpha interferon-resistant genotypes in hepatitis C patients
107. Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: Correlation with nucleotide sequencing
108. Simplified hepatitis C virus genotyping by heteroduplex mobility analysis
109. Evaluation of a novel serotyping system for hepatitis C virus: Strong correlation with standard genotyping methodologies
110. Serological determination of hepatitis C virus genotype: Comparison with a standardized genotyping assay